UR

Usha Rajeev

Active Director Director DIN 05018645
DIN 05018645 First appointment Sep 2014 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Sep 2014
Shareholding value •••• Premium profile

About Usha Rajeev

Data last updated:

Usha Rajeev is a Director at Carborundum Universal Limited (since 2024), Director at Paras Healthcare Limited (since 2024) and Director at Elantas Beck India Limited (since 2022). The companies operate in Manufacturing, Healthcare and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹7,395 Cr; the largest is Carborundum Universal Limited at ₹5,278 Cr (FY 2026). Earlier, Usha Rajeev was a Partner at Dalal & Shah Llp (2015–2018) and Partner at Price Waterhouse & Co Bangalore Llp (2014–2018) and 2 more.

DIN 05018645
Primary Designation Director
Industry Manufacturing
First Appointment 11 Sep 2014
Oldest Company Age 72 yrs
Largest company Carborundum Universal Limited · ₹5,278 Cr (FY 2026)
Combined revenue ₹7,395 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Carborundum Universal Limited L29224TN1954PLC000318
Director01 Aug 20241954₹5,278 Cr (FY 2026)Active
Paras Healthcare Limited U85110HR1987PLC035823
Director12 Jun 20241987₹1,314 Cr (FY 2025)Active
Elantas Beck India Limited L24222PN1956PLC134746
Director27 Jul 20221956₹803 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dalal & Shah Llp AAF-3596
Partner21 Dec 20152015Amalgamated
Partner01 Oct 20142014Active
Partner11 Sep 20142014₹25.2 Lakh (FY 2022)Active
Partner11 Sep 20142014Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Elantas Beck India Limited
Carborundum Universal Limited
Paras Healthcare Limited
Dalal & Shah Llp
Premium access

Shareholding and investment profile for Usha Rajeev

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Usha Rajeev

Usha Rajeev currently holds 3 directorships: Carborundum Universal Limited (Director, since 01 Aug 2024, revenue ₹5,278 Cr (FY 2026)); Paras Healthcare Limited (Director, since 12 Jun 2024, revenue ₹1,314 Cr (FY 2025)); Elantas Beck India Limited (Director, since 27 Jul 2022, revenue ₹803 Cr (FY 2024)).

Usha Rajeev was first appointed on 11 Sep 2014 as Partner at Lovelock & Lewes Llp. The most recent appointment on record is 01 Aug 2024 at Carborundum Universal Limited.

The 3 current companies of Usha Rajeev that report revenue have a combined latest revenue of ₹7,395 Cr: Carborundum Universal Limited ₹5,278 Cr (FY 2026); Paras Healthcare Limited ₹1,314 Cr (FY 2025); Elantas Beck India Limited ₹803 Cr (FY 2024).

Usha Rajeev held 4 earlier board appointments: Dalal & Shah Llp (Partner, 21 Dec 2015 to 01 Jun 2018); Price Waterhouse & Co Bangalore Llp (Partner, 01 Oct 2014 to 01 Jun 2018); Lovelock & Lewes Llp (Partner, 11 Sep 2014 to 01 Jun 2018); Price Waterhouse & Co Chartered Accountants Llp (Partner, 11 Sep 2014 to 01 Jun 2018).

The current boards of Usha Rajeev's companies include Bala Venkatesh Varma Datla (Carborundum Universal Limited), Muthiah Murugappan (Carborundum Universal Limited), Muthiah Murugappan Murugappan (Carborundum Universal Limited), Rangarajan Sridharan (Carborundum Universal Limited), Sujjain Suresh Talwar (Carborundum Universal Limited), Surendhiran Rekha (Carborundum Universal Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available